Medicofarma Biotech SA (WSE:MDB)

Poland · Delayed Price · Currency is PLN

0.4500

-0.0080 (-1.75%)

At close: Jun 15, 2026

69.81% (1Y)

Market Cap	30.59M +74.4%
Revenue (ttm)	43.90K -90.5%
Net Income	-2.08M
EPS	-0.03
Shares Out	67.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,343
Open	0.4580
Previous Close	0.4580
Day's Range	0.4280 - 0.4660
52-Week Range	0.2440 - 1.4000
Beta	0.84
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Medicofarma Biotech

Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in Feb... [Read more]

Industry Biotechnology & Medical Research

Sector Healthcare

Founded 2001

Employees 7

Stock Exchange Warsaw Stock Exchange

Ticker Symbol MDB

Full Company Profile

Financial Performance

In 2025, Medicofarma Biotech's revenue was 119,900, a decrease of -90.21% compared to the previous year's 1.22 million. Losses were -2.23 million, -3.05% less than in 2024.

Financial Statements